Legal Representation
Attorney
Andrew N. Spivak
USPTO Deadlines
Next Deadline
341 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20201208)
Due Date
December 08, 2026
Grace Period Ends
June 08, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
34 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 8, 2025 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Dec 8, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Sep 22, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 22, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 2, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 19, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 18, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 18, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 18, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 21, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 21, 2020 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 21, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 20, 2020 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Jun 23, 2020 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
| Jun 10, 2020 | FIXD | O | ELECTRONIC RECORD REVIEW COMPLETE | Loading... |
| Jun 5, 2020 | ERRR | O | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | Loading... |
| Jun 2, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 2, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 2, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 27, 2020 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| May 11, 2020 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| May 11, 2020 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| May 11, 2020 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| May 8, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 8, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 7, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| May 4, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 26, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 26, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 26, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 26, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 11, 2020 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jan 10, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 10, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer
Class 042
Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis services relating to the production of antibodies; scientific and technological services, namely, scientific research, analysis, and testing in the field of antibodies, and research and design relating thereto; industrial analysis and research services in the field of antibodies
Additional Information
Design Mark
The mark consists of the stylized, capitalized, teal word "DANYELZA" with three stacked V-shapes emanating from the top of the letter "Y", with the first in purple, the second in light green, and the third in the same teal color. Left-justified beneath the word "DANYELZA", in all lower-case letters and in a different font, is the word "NAXITAMAB" in gray.
Color Claim
The color(s) teal, purple, light green, and gray is/are claimed as a feature of the mark.
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"NAXITAMAB"